|
Volumn 87, Issue 8, 2002, Pages 3562-3572
|
Levonorgestrel implants (Norplant II) for male contraception clinical trials: Combination with transdermal and injectable testosterone
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FOLLITROPIN;
LEVONORGESTREL;
LUTEINIZING HORMONE;
SEX HORMONE BINDING GLOBULIN;
TESTODERM TTS;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ACNE;
ADULT;
ARTICLE;
AZOOSPERMIA;
BODY WEIGHT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG IMPLANTATION;
GYNECOMASTIA;
HORMONAL CONTRACEPTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
OLIGOSPERMIA;
PRIORITY JOURNAL;
TESTIS SIZE;
URTICARIA;
ADMINISTRATION, CUTANEOUS;
ADOLESCENT;
ADULT;
BODY WEIGHT;
COITUS;
CONTRACEPTION;
CONTRACEPTIVE AGENTS, MALE;
DRUG IMPLANTS;
FOLLICLE STIMULATING HORMONE;
GONADAL STEROID HORMONES;
HUMANS;
LEVONORGESTREL;
LUTEINIZING HORMONE;
MALE;
MIDDLE AGED;
SEX HORMONE-BINDING GLOBULIN;
SPERMATOGENESIS;
TESTIS;
TESTOSTERONE;
ILEX COOKII;
INSERTION SEQUENCES;
|
EID: 0036348463
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jc.87.8.3562 Document Type: Article |
Times cited : (103)
|
References (29)
|